RFA
AGRX

Reilly Financial Advisors’s Agile Therapeutics AGRX Stock Holding History

Reilly Financial Advisors’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2K Buy
+2
New +$2.82K ﹤0.01% 1028
2021
Q3 		– Sell
-2
Closed -$4K – 1096
2021
Q2 		$4K Hold
2
– – ﹤0.01% 843
2021
Q1 		$6K Buy
+2
New +$10.8K ﹤0.01% 776
2019
Q4 		– Sell
-9
Closed -$21K – 943
2019
Q3 		$21K Buy
+9
New +$22.2K ﹤0.01% 500

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Reilly Financial Advisors's AGRX Position: Q4 2021 in Review

Reilly Financial Advisors opened a new position in Agile Therapeutics (AGRX) in Q4 2021: 2 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1028 among its holdings. This is a return to the name: Reilly Financial Advisors previously reported a position in AGRX as recently as Q2 2021.

Reilly Financial Advisors first reported a position in AGRX in Q3 2019 and has held it in 4 quarters since. The position peaked at $21K in Q3 2019. 45 funds tracked by Wall St. Rank hold AGRX as of Q4 2021.

  • Reilly Financial Advisors held 2 shares of Agile Therapeutics worth $2K as of Q4 2021.
  • Agile Therapeutics was a new Reilly Financial Advisors position in Q4 2021.
  • Agile Therapeutics made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #1028 holding.
  • Reilly Financial Advisors first reported a position in Agile Therapeutics in Q3 2019 and has held it in 4 quarters since.
  • Reilly Financial Advisors's Agile Therapeutics position peaked at $21K in Q3 2019.
  • 45 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.